drugset
drugset / Trial / NCT05271708

Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery

NCT05271708 ↗

Phase 4 Completed 46 enrolled National Defense Medical Center, Taiwan
Non-randomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to evaluate the efficacy of the Fespixon cream for prevention and/or appearance reduction of different types of linear scars during the 12-week treatment phase, which is assessed by the blinded independent evaluator.

Timeline

Start
2022-01-05
Primary completion
2022-10-17
Completion
2022-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Fespixon Unknown — Topical

Indications

No indication recorded.